Literature DB >> 20362478

TEThered to Runx: novel binding partners for runx factors.

Xiaodong Li1, Matthew Decker, Jennifer J Westendorf.   

Abstract

RUNX transcription factors reside in the nuclear matrix where they integrate numerous signaling pathways to regulate gene expression and affect tissue development, regeneration, and tumorigenesis. An affinity purification and proteomic experiment was performed to identify novel Runx2 binding partners. The interactions between Runx2 and two nuclear factors (Ddx5 and CoAA) identified in this screen were previously described. Coactivator activator (CoAA) bound the DNA binding domain of Runx2 and prevented Runx-driven gene expression. The YxxQ motif in CoAA was required for Runx2 interactions. Members of the FET/TET family of proteins, including FUS/TLS and EWSR1, contain a similar motif and were hypothesized to interact with Runx2. Here, we provide evidence that FUS/TLS, EWSR1, and the Ewing's sarcoma t(12;21) fusion protein EWS-FLI bind Runx2 and alter its transcriptional activity. Potential roles of protein complexes containing FET/TET and RUNX family members during tumor formation and mesenchymal progenitor cell differentiation are discussed. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362478      PMCID: PMC2878890          DOI: 10.1016/j.bcmd.2010.03.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  34 in total

1.  Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours.

Authors:  O Delattre; J Zucman; B Plougastel; C Desmaze; T Melot; M Peter; H Kovar; I Joubert; P de Jong; G Rouleau
Journal:  Nature       Date:  1992-09-10       Impact factor: 49.962

2.  Runt-related gene 2 in endothelial cells: inducible expression and specific regulation of cell migration and invasion.

Authors:  L Sun; M Vitolo; A Passaniti
Journal:  Cancer Res       Date:  2001-07-01       Impact factor: 12.701

Review 3.  The TET family of proteins: functions and roles in disease.

Authors:  Adelene Y Tan; James L Manley
Journal:  J Mol Cell Biol       Date:  2009-09-24       Impact factor: 6.216

4.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1.

Authors:  H Miyoshi; K Shimizu; T Kozu; N Maseki; Y Kaneko; M Ohki
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

5.  Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2.

Authors:  E Zelzer; D J Glotzer; C Hartmann; D Thomas; N Fukai; S Soker; B R Olsen
Journal:  Mech Dev       Date:  2001-08       Impact factor: 1.882

6.  The Ewing's sarcoma gene product functions as a transcriptional activator.

Authors:  K L Rossow; R Janknecht
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

7.  Differentiation-dependent interactions between RUNX-1 and FLI-1 during megakaryocyte development.

Authors:  Hui Huang; Ming Yu; Thomas E Akie; Tyler B Moran; Andrew J Woo; Nathan Tu; Zachary Waldon; Yin Yin Lin; Hanno Steen; Alan B Cantor
Journal:  Mol Cell Biol       Date:  2009-05-26       Impact factor: 4.272

8.  Runx2 deficiency in chondrocytes causes adipogenic changes in vitro.

Authors:  Hirayuki Enomoto; Tatsuya Furuichi; Akira Zanma; Kei Yamana; Carolina Yoshida; Satoru Sumitani; Hiroyasu Yamamoto; Motomi Enomoto-Iwamoto; Masahiro Iwamoto; Toshihisa Komori
Journal:  J Cell Sci       Date:  2004-01-26       Impact factor: 5.285

9.  Co-activator activator (CoAA) prevents the transcriptional activity of Runt domain transcription factors.

Authors:  Xiaodong Li; Luke H Hoeppner; Eric D Jensen; Rajaram Gopalakrishnan; Jennifer J Westendorf
Journal:  J Cell Biochem       Date:  2009-10-01       Impact factor: 4.429

10.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma.

Authors:  A Crozat; P Aman; N Mandahl; D Ron
Journal:  Nature       Date:  1993-06-17       Impact factor: 49.962

View more
  14 in total

Review 1.  Glucocorticoid-Induced Osteoporosis.

Authors:  Baruch Frenkel; Wendy White; Jan Tuckermann
Journal:  Adv Exp Med Biol       Date:  2015       Impact factor: 2.622

2.  Knockdown of PRKAR1A, the gene responsible for Carney complex, interferes with differentiation in osteoblastic cells.

Authors:  Mei Zhang; Parmeet K Manchanda; Dayong Wu; Qianben Wang; Lawrence S Kirschner
Journal:  Mol Endocrinol       Date:  2014-02-07

3.  The Ewing's sarcoma fusion protein, EWS-FLI, binds Runx2 and blocks osteoblast differentiation.

Authors:  Xiaodong Li; Meghan E McGee-Lawrence; Matthew Decker; Jennifer J Westendorf
Journal:  J Cell Biochem       Date:  2010-11-01       Impact factor: 4.429

4.  ODAM Expression Inhibits Human Breast Cancer Tumorigenesis.

Authors:  Daniel P Kestler; James S Foster; Charles T Bruker; John W Prenshaw; Stephen J Kennel; Jonathan S Wall; Deborah T Weiss; Alan Solomon
Journal:  Breast Cancer (Auckl)       Date:  2011-04-28

5.  RUNX3 facilitates growth of Ewing sarcoma cells.

Authors:  Krista L Bledsoe; Meghan E McGee-Lawrence; Emily T Camilleri; Xiaoke Wang; Scott M Riester; Andre J van Wijnen; Andre M Oliveira; Jennifer J Westendorf
Journal:  J Cell Physiol       Date:  2014-12       Impact factor: 6.384

Review 6.  TDP-43/FUS in motor neuron disease: Complexity and challenges.

Authors:  Erika N Guerrero; Haibo Wang; Joy Mitra; Pavana M Hegde; Sara E Stowell; Nicole F Liachko; Brian C Kraemer; Ralph M Garruto; K S Rao; Muralidhar L Hegde
Journal:  Prog Neurobiol       Date:  2016-09-28       Impact factor: 11.685

7.  Initial Characterization of Osteoblast Differentiation and Loss of RUNX2 Stability in the Newly Established SK11 Human Embryonic Stem Cell-Derived Cell Line.

Authors:  Jia-Li Yu; Helty Adisetiyo; Gillian H Little; C Thomas Vangsness; Jianjie Jiang; Hal Sternberg; Michael D West; Baruch Frenkel
Journal:  J Cell Physiol       Date:  2015-02       Impact factor: 6.384

8.  Minor intron splicing is regulated by FUS and affected by ALS-associated FUS mutants.

Authors:  Stefan Reber; Jolanda Stettler; Giuseppe Filosa; Martino Colombo; Daniel Jutzi; Silvia C Lenzken; Christoph Schweingruber; Rémy Bruggmann; Angela Bachi; Silvia Ml Barabino; Oliver Mühlemann; Marc-David Ruepp
Journal:  EMBO J       Date:  2016-06-01       Impact factor: 11.598

9.  Allosteric interference in oncogenic FLI1 and ERG transactions by mithramycins.

Authors:  Caixia Hou; Abhisek Mandal; Jürgen Rohr; Oleg V Tsodikov
Journal:  Structure       Date:  2020-12-03       Impact factor: 5.006

10.  Dr. Jekyll and Mr. Hyde: The Two Faces of the FUS/EWS/TAF15 Protein Family.

Authors:  Heinrich Kovar
Journal:  Sarcoma       Date:  2010-12-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.